These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1509407)

  • 1. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting.
    Scandella D; Timmons L; Mattingly M; Trabold N; Hoyer LW
    Thromb Haemost; 1992 Jun; 67(6):665-71. PubMed ID: 1509407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
    Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
    Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
    Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
    Lollar P
    Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of biologically active human factor VIII using a baculovirus vector.
    Webb E; Tkalcevic J; Edwards S; Hocking D; Nisbet I
    Biochem Biophys Res Commun; 1993 Jan; 190(2):536-43. PubMed ID: 8427596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.
    Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H
    Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2.
    Scandella D; Mattingly M; Prescott R
    Blood; 1993 Sep; 82(6):1767-75. PubMed ID: 7691236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
    Scandella D
    Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope localization of anti-factor VIII monoclonal antibodies determined by recombinant peptides.
    Ware J; Toomey JR; Stafford DW
    Thromb Haemost; 1989 Apr; 61(2):225-9. PubMed ID: 2473538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII.
    Kurasawa JH; Shestopal SA; Jha NK; Ovanesov MV; Lee TK; Sarafanov AG
    Protein Expr Purif; 2013 Apr; 88(2):201-6. PubMed ID: 23306063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
    Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.
    Sarafanov AG; Makogonenko EM; Andersen OM; Mikhailenko IA; Ananyeva NM; Khrenov AV; Shima M; Strickland DK; Saenko EL
    Thromb Haemost; 2007 Dec; 98(6):1170-81. PubMed ID: 18064310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.